Somite.ai leverages big data and AI to introduce novel cell replacement therapies, self-described as the only company proficient in producing somite-derived cells efficiently.
investor of
Metrics
marketPRIVATE
msh_idAI:SOMITE
localeus
websitehttps://somite.ai/
founding_date2020-07-31
source_ref04bee0ac-b770-41cf-9ff6-2bcfaa035364
company_size2
products_or_servicesArtificial Intelligence-driven cell replacement therapies and novel protocols for generating new cell types.
United States